Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis.

Lancet (London, England) ·Vol. 1 ·No. 7636 ·1970-01-03 ·Pages 9-14

Wright GL, Harper J

Abstract

暂无摘要

MeSH Terms

Adolescent Bronchopneumonia/complications Child Child, Preschool Chloramphenicol/administration & dosage Cloxacillin/administration & dosage Cystic Fibrosis/drug therapy Female Fusidic Acid/administration & dosage Humans Infant Lincomycin/administration & dosage Male Neomycin/administration & dosage Novobiocin/administration & dosage Penicillin Resistance Penicillin V/administration & dosage Pseudomonas Infections/complications Staphylococcal Infections/drug therapy Tetracycline/administration & dosage

Chemicals

Novobiocin Fusidic Acid Chloramphenicol Lincomycin Tetracycline Neomycin Cloxacillin Penicillin V

Authors & Affiliations

2 authors, click to expand affiliations / ORCID

Wright G L

Harper J

Article Info

Journal

Lancet (London, England)

Abbr.

Lancet

ISSN

0140-6736

DOI

10.1016/s0140-6736(70)90523-4

Published

1970-01-03

Pages

9-14

Language

English

Region

England

NLM ID

2985213R

Subset

External Links

PubMed source DOI: 10.1016/s0140-6736(70)90523-4 View journal details

Analysis Services

Fusidic acid and lincomycin therapy in staphylococcal infections in cystic fibrosis.

Contact

WeChat Official Account